|Previous Section||Index||Home Page|
|Number of individual work permit applications approved for doctors and nurses from Guyana for the last nine years|
|(1) Indicates one or two.|
1. Figures are rounded to nearest five.
2. Because of rounding, figures may not add up to totals shown.
3. The occupational categories used are not ONS standard occupational classifications (SOC).
4. The figures quoted are not provided under national statistics protocols and have been derived from local management information and are therefore provisional and subject to change.
The figures do not equate to the number of individual nationals who were granted permits because they include those applications approved to extend or amend an existing permit or where the individual has moved to another job with a different employer. Not all those who were granted a permit took up the job and some may have been refused entry clearance or further leave to remain.
Mike Penning: To ask the Secretary of State for Health (1) what assessment he has made of the impact of the use of the NHS Pathways system by North East Ambulance Service on those patients who required an ambulance as part of their care; 
Mr. Bradshaw: The Department commissioned a research evaluation of the accuracy and safety of NHS Pathways by a group of researchers from three universities. The research looked at all types of patients assessed by NHS Pathways, including those who needed an ambulance. A copy of the evaluation, An evaluation of the accuracy and safety of NHS Pathways, has been placed in the Library. Information is not available centrally on the cost of the trial of the NHS Pathways system by North East Ambulance Service as these costs were met locally.
Lynne Featherstone: To ask the Secretary of State for Health when the National CJD Surveillance Unit informed his Department of evidence of infection of a patient with a bleeding disorder with vCJD transmitted by a transfusion; and if he will make a statement. 
Dawn Primarolo: The information on the finding of abnormal prion protein associated with variant Creutzfeldt-Jakob Disease (vCJD) in a spleen sample taken from a haemophilia patient at post mortem, was presented to the Department by National CJD Surveillance Unit on 6 January 2009. Before the finding was made public on 17 February, it was important to find out information about the patients possible routes of exposure to abnormal prion protein associated with vCJD. The Health Protection Agency and the UK Haemophilia Centre Doctors Organisation worked to prepare accurate information packs and letters for haemophilia centre doctors and their patients.
Lynne Featherstone: To ask the Secretary of State for Health what estimate he has made of the potential financial liability to the NHS arising from claims from patients with bleeding disorders infected with vCJD from NHS transfusions; and if he will make a statement. 
Dawn Primarolo: No such estimate has been made. The vCJD Trust is available to pay compensation to patients with clinical variant Creutzfeldt-Jakob Disease (vCJD) and their families and carers. No patients with bleeding disorders have been diagnosed with clinical vCJD.
Mr. Vara: To ask the Secretary of State for Health how much on average was spent on treating a breast cancer patient by each primary care trust in each strategic health authority in each of the last five years. 
Ann Keen: The information is not available in the format requested. The following table shows an estimate of the gross expenditure on cancers and tumours by the national health service in England for all cancer and tumour types for the last four available financial years. This information was first collected in 2003-04 and is not available for any previous years.
|Estimated gross expenditure on cancer and tumours (all types) and on breast cancers and tumours from 2003-04 to 2006-07|
|Financial year||Gross expenditure on cancers and tumoursall types||Gross expenditure on breast cancers and tumours|
Department of Health Resource Accounts.
Mr. Gray: To ask the Secretary of State for Health what proportion of adults in (a) North Wiltshire constituency, (b) Wiltshire and (c) England received treatment from a dentist under the NHS in each of the last 10 years. 
The proportion of the adult population registered with a national health service dentist in England, as at 31 March, 1997 to 2006 is available in Annex B of the NHS Dental Activity and Workforce Report, England: 31 March 2006. Information is provided by primary care trust (PCT) and by strategic health authority (SHA).
This information is based on the old contractual arrangements which were in place up to and including 31 March 2006. This report has already been placed in the Library and is also available on the NHS Information Centre website at:
Under the new dental contractual arrangements, introduced on 1 April 2006, patients do not have to be registered with an NHS dentist to receive NHS care. The closest equivalent measure to registration is the number of patients receiving NHS dental services (patients seen) over a 24-month period. However, this is not directly comparable to the registration data for earlier years.
Information on adult patients seen in the previous 24 months as a percentage of the adult population in England is available in Table D5 Annex 3 of the NHS Dental Statistics, Quarter 2: 30 September 2008 report. Information is available at quarterly intervals, from 31 March 2006 to 30 September 2008 and is provided by PCT and SHA.
Mr. Bradshaw: The Government welcomed the promise as a commendable initiative to raise awareness of the importance of effective data protection safeguards, particularly for those organisations with no similar commitments already in place.
The Ministry of Justice is considering actively with the Information Commissioners Office how the promise might add additional value to those measures we have already signed up to. These include the information charters, the recommendations of the Data Handling review and the Thomas/Walport review and, of course, our legal obligations under the Data Protection Act 1998 and other legislation and regulations.
Mrs. Laing: To ask the Secretary of State for Health what the cost of maintaining the databases owned and managed by (a) his Department and (b) its agencies was in (i) 2006, (ii) 2007 and (iii) 2008. 
Mr. Bradshaw: The Department has in excess of 200 database information owners. The cost of undertaking an exercise to determine the cost of maintenance and management would incur disproportionate cost for the Department alone. As a consequence, a response has not been requested from its agencies.
The Departments website complies with the World Wide Web Consortiums (W3Cs) Level A guidelines for accessibility. The Government web guidelines published by the Cabinet Office-Central Office of Information require all websites operated by central Government departments to be double-A conformant by December 2009.
Mrs. Curtis-Thomas: To ask the Secretary of State for Health what private finance initiative projects his Department has entered into since 1997; what the total value of each contract was; who the successful contractor was; which projects have been subject to refinancing arrangements; what the monetary value of the refinancing arrangement was in each such case; and what the extent of the clawback has been. 
Mr. Bradshaw: Information on the capital value and estimated revenue payments for the lifetime of each private finance contract as well as the primary contractors (equity stakeholders in the project companies) involved has been placed in the Library.
Private finance initiative schemes which have been the subject of a refinancing agreement together with details of the value and the extent of the clawback to the NHS trust in each case are shown in the following table.
|Scheme||Date refinanced||Total refinancing gain (net present values £ million)||Trusts share of refinancing share (percentage)||Trust s share of refinancing gain (net present values £ million)|
The Medical Research Council (MRC) is one of the main agencies though which the Government support medical and clinical research. The MRC is an independent body funded by the Department for Innovation, Universities and Skills.
The MRC is currently funding one research project relating to Downs syndrome. The MRC does not, as a rule, earmark funds for particular topics: research proposals in all areas compete for the funding available. The MRC always welcomes high quality applications for support into any aspect of human health and these are judged in open competition with other demands on funding. Awards are made according to their scientific quality and importance to human health.
|Next Section||Index||Home Page|